Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−39.005EUR
−23.49 MEUR
5.91 M
About PHAXIAM THERAPEUTICS
Sector
CEO
Thibaut du Fayet
Headquarters
Lyon
Website
Employees (FY)
68
Founded
2004
ISIN
FR001400K4B1
FIGI
BBG004G3ZZS1
PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PHXM is 2.960 EUR — it has increased by 0.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange PHAXIAM THERAPEUTICS stocks are traded under the ticker PHXM.
PHAXIAM THERAPEUTICS is going to release the next earnings report on Sep 25, 2024. Keep track of upcoming events with our Earnings Calendar.
PHXM stock is 2.07% volatile and has beta coefficient of −0.08. Check out the list of the most volatile stocks — is PHAXIAM THERAPEUTICS there?
Yes, you can track PHAXIAM THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
PHXM stock has risen by 2.78% compared to the previous week, the month change is a 2.07% rise, over the last year PHAXIAM THERAPEUTICS has showed a 63.23% decrease.
PHXM net income for the last quarter is −11.29 M EUR, while the quarter before that showed −12.20 M EUR of net income which accounts for 7.49% change. Track more PHAXIAM THERAPEUTICS financial stats to get the full picture.
No, PHXM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHXM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHAXIAM THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
As of May 1, 2024, the company has 68.00 employees. See our rating of the largest employees — is PHAXIAM THERAPEUTICS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHAXIAM THERAPEUTICS technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHAXIAM THERAPEUTICS stock shows the sell signal. See more of PHAXIAM THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PHAXIAM THERAPEUTICS future price: according to them, PHXM price has a max estimate of 8.00 EUR and a min estimate of 5.70 EUR. Read a more detailed PHAXIAM THERAPEUTICS forecast: see what analysts think of PHAXIAM THERAPEUTICS and suggest that you do with its stocks.